A genome-wide association study of serum uric acid (SUA) laevels was performed in a relatively isolated population of European descent from an island of the Adriatic coast of Croatia. The study sample included 532 unrelated and 768 related individuals from 235 pedigrees. Inflation due to relatedness was controlled by using genomic control. Genetic association was assessed with 2,241,249 single nucleotide polymorphisms (SNPs) in 1300 samples after adjusting for age and gender. Our study replicated four previously reported SUA loci (SLC2A9, ABCG2, RREB1, and SLC22A12). The strongest association was found with a SNP in SLC2A9 (rs13129697, P = 2.33×10 −19 ), which exhibited significant gender-specific effects, 35.76 μmol/L (P = 2.11×10 −19 ) in females and 19.58 μmol/L (P = 5.40×10 −5 ) in males. Within this region of high linkage disequilibrium, we also detected a strong association with a nonsynonymous SNP, rs16890979 (P = 2.24×10 −17 ), a putative causal variant for SUA variation. In addition, we identified several novel loci suggestive of association with uric acid levels (SEMA5A, TMEM18, SLC28A2, and ODZ2), although the P-values (P < 5×10 −6 ) did not reach the threshold of genome-wide significance. Together, these findings provide further confirmation of previously reported uric-acid-related genetic variants and highlight suggestive new loci for additional investigation.
Introduction
Genome-wide association studies (GWAS) have uncovered over 30 common sequence variants influencing serum uric acid (SUA) concentration and gout (Hindorff et al., 2011) . Among these, the most significant findings are the singlenucleotide polymorphisms (SNPs) located within the solute carrier family 2 member 9 (SLC2A9) gene on chromosome 4, which have been consistently replicated across multiple populations (Charles et al., 2011; Dehghan et al., 2008; Döring et al., 2008; Kolz et al., 2009; Li et al., 2007; McArdle et al., 2008; Vitart et al., 2008; Wallace et al., 2008; Yang et al., 2010) . Additional GWAS and metaanalyses have identified variants in several other genes including PDZK1, GCKR, ABCG2, RREB1, LRRC16A, SLC17A1, SLC17A3, SLC22A11 , and SLC22A12 that have reached genome-wide significance levels (Dehgan et al., 2008; Kolz et al., 2009; Yang et al., 2010) . We conducted a GWAS of metabolic traits, including SUA concentration, in a relatively isolated population from the Adriatic coast of Croatia. This study strongly replicated the SLC2A9 findings and identified several suggestive novel loci that may represent genuine effects. In addition, our study also replicated associations of SNPs in ABCG2, RREB1, and SLC22A12, although the signals did not reach genome-wide significance.
Materials and Methods

Subjects
The study population has been described previously (Karns et al., 2011; Zhang et al., 2010) . Briefly, participants were derived from the middle Dalmatian island of Hvar on the eastern Adriatic coast of Croatia. The population is primarily of Slavic descent, which had emigrated from the mainland before the 18th century and remained relatively isolated since that time (Rudan et al., 1992) . Phenotypic measures and blood samples were collected in two field surveys conducted in May 2007 and May 2008, with no consideration of disease status or medication. Blood samples were collected following an overnight fast, and SUA levels were measured using the enzymatic color method. In total, 1395 related and unrelated subjects aged >20 years with SUA measures were included in the current study. Descriptive statistics of quantitative traits (age, body mass index, fasting plasma glucose, and blood pressure) and prevalence of four metabolic disorders (type 2 diabetes, hypertension, gout, and metabolic syndrome) are provided in Supplementary Table S1 . Data on type 2 diabetes, gout, and hypertension were collected through self-reports, medical review, and clinical diagnostic measures. The study was approved by the Ethics Committee of the Institute for Anthropological Research in Zagreb, Croatia, and the Institutional Review Board of the University of Cincinnati.
Genotyping
Genome-wide SNP genotyping was performed using the Affymetrix Human SNP Array 5.0 following the manufacture's protocol. Genotype calls were determined using the CRLMM algorithm (Carvalho et al., 2007 (Carvalho et al., , 2010 among chips that passed the prescribed Dynamic Model genotyping QC call rate (>0.86). Following further QC filtering of the genotype data (MAF > 0.02, HWE P > 0.0001, call rate >95%) using the check.marker function implemented in GenABEL , we obtained a cleaned data set of 344,512 SNPs in 1300 samples (563 males and 737 females). From this cleaned data set, we performed genotype imputation using MACH (Li et al., 2009 ) and the reference haplotype data from the Phase II CEU HapMap (International HapMap Consortium, 2007) . The same QC procedures were performed on the imputed data, yielding a final genotype data set of 2,241,249 SNPs in 1300 samples.
Statistical Analysis
All statistical analyses were performed in R v2.11; genomewide association analysis was performed using the GenABEL package (v.1.6). Single-locus tests adjusted for age and sex were conducted using the qtscore routine. Since our samples included 532 unrelated as well as 768 related individuals from 235 families, genomic control (GC) was applied to correct for inflation due to inclusion of related individuals (Devlin & Roeder, 1999; Devlin et al., 2001) . The inflation factor (λ) was estimated using the median method (Bacanu et al., 2002) , and P-values based on the adjusted test statistics (1 d.f. assuming additive effects) were reported. Association signals of significant regions were plotted using LocusZoom (Pruim et al., 2010) .
Results
SUA levels were normally distributed in both males (N = 563) and females (N = 737) and the mean levels were significantly higher in males (361.0±79.19 μmol/L) than females (265.4±77.65 μmol/L), though Bartlett's and Fligner's tests revealed no significant gender-based differences in SUA variance. Regression analysis indicated that SUA levels were significantly associated with age in both genders and the association was more significant in females. SUA change per year in females was 1.797 μmol/L (P = 2.2×10 −24 , r 2 = 13.1%) and in males was 0.786 μmol/L (P = 0.00019, r 2 = 2.28%) ( Supplementary Fig. S1 ).
As anticipated from the relatedness among the samples, the test statistics were inflated compared to the null distribution with an estimated inflation factor λ = 1.20. As shown in the quantile-quantile (QQ) plot ( Supplementary Fig. S2 ), after adjustment for this inflation factor and exclusion of significant SNPs in the SLC2A9 region, the test statistics fit well with the expected values, indicating appropriate control of false positive rate.
A Manhattan plot of the genome-wide association signals ( Fig. 1) shows the strongest association around the SLC2A9 gene, a well-established uric-acid-associated gene. The significant region spans roughly 650 kb and covers the SLC2A9 and the WDR1 genes (Fig. 2 ). This region is delimited by two recombination hot spots with local recombination rate >25 cM/Mb. One-hundred sixteen SNPs with P-value less than the genome-wide significant level (5×10 −8 ) were identified within this region. The strongest signal was found on the imputed SNP rs13129697 (P = 2.33×10 −19 ); the minor allele was associated with an average SUA decrease of 28.99 μmol/L. Consistent with previous studies, the effect size estimate showed substantial gender difference with 35.76 μmol/L (P = 2.11×10 −19 ) in females and 19.58 μmol/L (P = 5.40×10
−5 ) in males. This pattern was similar across all of the 116 SNPs that reached genome-wide significance. Of interest is a nonsynonymous SNP, rs16890979 (P = 2.24×10 −17 ), also reported previously with and 5×10 −6 . Six regions that reach suggestive genome-wide significance (P < 5×10 −6 ) are highlighted with names of nearby genes. Gene names in black are previously reported uric acid associated genes. (rs13129697) is color-coded. Size of each dot indicates whether the SNP is a genotyped (large) or imputed (small). The light blue curve shows the local recombination rate based on HapMap Phase II data. rs16890979 is the nonsynonymous SNP and rs874432 is the most significant genotyped SNP.
genome-wide significance (Dehghan et al., 2008; McArdle et al., 2008) . Reanalysis of the region, conditional on either rs13129697 or rs16890979, failed to completely abolish the signals of the other SNPs with the smallest conditional P∼1.7×10 −3 (data not shown), suggesting the possibility of multiple functional variants within the region.
In addition to the well-established SLC2A9 region, five other potentially significant regions (Table 1) were identified with at least one SNP above a threshold of P < 5×10 −6 . The most salient of these is a suggestive novel locus in an intergenic region on chromosome 5; the most significant variant, rs200113 (P = 7.02×10 −8 ), is located ∼400 kb Annals of Human Genetics (2012) 00,1-7 3 Note: Position is based on NCBI Genome Build 36; A1 and A2 are the major and minor alleles, respectively; Eff-All, Eff-M, and Eff-F are effect sizes (μmol/L) of the minor alleles in total, male and female samples. A significant region was selected starting with an "index" SNP (P < 5×10 −6 ) and was progressively extended to adjacent (<50 kb) significant SNPs (P < 5×10 −3 ). The ABCG2 region was included in the table although the P-value of the index SNP (rs2231142, 5.14×10
−06 ), a nonsynonymous variant, did not strictly reach the standard threshold (P < 5×10 −6 ).
downstream of the SEMA5A gene. The remaining four regions are located within or near the genes TMEM18, SLC28A2, ODZ2, and ABCG2, respectively. ABCG2 is a confirmed uric-acid-associated gene (Dehghan et al., 2008; Kolz et al., 2009; Yang et al., 2010) and the variant, showing the highest signal (P = 5.14×10 −6 ) is a nonsynonymous SNP (rs2231142, NP_004818.2, Gln141Lys) and the mutant allele associated with an average increase of 27.40 μmol/L (Supplementary Fig. S3 ). This SNP showed significant gender-specific effects, with 31.11 μmol/L in males compared to 22.97 μmol/L in females. Reanalysis conditional on this SNP explained all the association across the region, which is highly suggestive of this missense variant being the functional SNP at the ABCG2 locus.
To compare our findings with previous GWA studies, we analyzed 30 serum urate-or uric-acid-associated SNPs listed in the GWA catalog (six of the 36 reported SNPs were missing from our imputed and cleaned data set) ( Table 2 ). In addition to the aforementioned SLC2A9 and ABCG2 loci, we replicated associations with nominal significance (P < 0.05) at two additional loci, RREB1 (rs675209, P = 0.0032) and SLC22A12 (rs17300741, P = 0.0034). The effects of all significant SNPs were in the same direction as those reported in previous GWA studies.
Discussion
We present the results of a GWAS of SUA in an isolated island population based on 2,241,249 imputed and genotyped SNPs in 1300 samples. Our purpose was to replicate previously reported loci and uncover novel SUA-related loci, taking advantage of population attributes of limited admixture and homogeneous environmental exposures. We have used GC to provide correction for inflation due to relatedness while maximizing power to detect associations by including all samples. Previous study indicated that GC is a valid and powerful method for the analysis of pedigree-based quantitative trait loci (Amin et al., 2007) .
The most significant associations emerged from multiple SNPs in and around SLC2A9 on chromosome 4, a widely replicated SUA-associated region. The SNP with the strongest signal, rs13129697, is located in intron 7 of the gene. Of particular interest, however, was the association of rs16890979 (Val253Ile), a nonsynonymous imputed SNP that has been reported in previous GWAS (Dehghan et al., 2008; McArdle et al., 2008) .
We performed a comparative analysis of previously reported per-allele effect sizes of the significant SNPs in SLC2A9 and found that, in general, our effect sizes are somewhat higher than those reported in previous GWAS (Dehghan et al., 2008; Döring et al., 2008; Kolz et al., 2009; McArdle et al., 2008; Yang et al., 2010; Zemunik et al., 2009) (Supplementary  Fig. S4 ). Across studies, SLC2A9 variant effect sizes in females are markedly elevated compared to males. In our population, we found that males had significantly higher mean SUA concentrations, though female SUA concentration was more strongly associated with age. Sex-specific effects of SLC2A9 variants were more extensively examined by Döring et al. (2008) , who showed that in addition to genotypic effects, SLC2A9 expression levels were stronger in females. Together these observations suggest that the SLC2A9 variants may play a more significant role influencing uric acid concentrations in females, which could be due to physiological and vascular differences between males and females and due to decreased uricosuric-related estrogen action following menopause (Adamopoulos et al., 1977; Puig et al., 1991) . In addition, they suggest a potential gene-environment interaction that may be related to the gender-specific effects of the SLC2A9 variants. In addition to reconfirming the SLC2A9 locus, we provide replications for three previously reported GWAS loci (ABCG2, RREB1, and SLC22A12), though the P-values do not reach strict GWAS significance. We report significant gender-specific effects of a nonsynonymous variant in ABCG2, similar to those previously reported by Kolz et al. (2009) . In addition to the replicated regions, we observed suggestive association signals (P < 5×10 −6 ) at several novel loci. The most significant was a SNP (rs200113) located downstream of SEMA5A, which encodes the semaphorin-5A protein. SNPs in its vicinity were significantly associated with Parkinson's disease and autism in separate GWAS (Maraganore et al., 2005; Weiss et al., 2009) . While elevated uric acid is correlated with lower risk of developing Parkinson's disease (Alonso et al., 2007; Davis et al., 1996; de Lau et al., 2005; Weisskopf et al., 2007) , apart from a hyperuricosuric subtype of autism (Page & Coleman, 2000) , no link between autism and uric acid has been reported.
In summary, our study replicated four previously reported SUA associated loci (SLC2A9, ABCG2, RREB1, and SLC22A12) with different levels of significance, and detected suggestive associations at several novel loci (SEMA5A, TMEM18, SLC28A2, and ODZ2) that did not reach the threshold of genome-wide significance. However, due to the moderate sample size and the lack of a replication cohort, the observed associations at these novel loci are preliminary and require further exploration and confirmation in other populations.
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